Topical Dosage Form Classification/Nomenclature Questions Advisory Committee of Pharmaceutical Science Meeting March 12, 2003 Yuan-yuan Chiu, Ph.D. Director,

Slides:

Advertisements

Similar presentations

Presentation By Jaspreet Rekhi Introducing Sites: -

Advertisements

Quality by Design for Topical Dosage Forms

Bioequivalence of Topical Products

CREAM Introduction and its types

Stability data required by WHO-PQP Mercy Acquaye.

Separation of molecules and determination of there molecular weight by gel filtration chromatography. Experiment 7 BCH 333.

Presented at the Advisory Committee for Pharmaceutical Science meeting on March 12, 2003 by Lucinda Buhse, Ph.D.

Mixtures Mr. Skirbst Physical Science Topic Classes of Matter.

Proposed Definitions and Decision Tree for Topical Dosage Forms Advisory Committee for Pharmaceutical Science March 12, 2003 Chi-wan Chen, Ph.D. Director,

CREAMS MS.WAJIHA IFFAT OBJECTIVES: After the end of this topic, the student will be able to : Define creams Classify creams Method of preparation prepare.

Gels and Gelformation. Colloidal Gel Structures (Wolfgang Ostwald) Semisolids, consisting of at least two components: The first component, being in the.

EMULSIONS Kh Sadique Faisal Asst

PRINCIPLES OF COMPOUNDING

Topical Dermatologic Dosage Forms and Vehicle Properties: Issues and Opportunities Jonathan Wilkin, M.D. Director, Division of Dermatologic and Dental.

Pharmaceutical Nomenclature Issues and challenges Moheb M. Nasr, Ph.D. Acting Director Office of New Drug Chemistry (ONDC) OPS, CDER, FDA Advisory Committee.

Title Page Name of PI and Co PI March 6, 2008 Oversight Committee Presentation.

Colloid & Surface Phenomena Loition Jason Ashbery Jonathan Danner Haohao Huang Leigh Vorreuter.

An Introduction to Chemistry Foundations of College Chemistry, 14 th Ed. Morris Hein and Susan Arena The vibrant colors of the aurora borealis are the.

EMULSIONS Heterogeneous systems consisting of at least one immiscible liquid phase intimately dispersed throughout a second phase in the form of droplets.

Semisolid Dosage Forms 312 PHT

Pharmaceutics 2 & 3 صيدلانيات 2&3 Unit / second semester

Semisolid Dosage Forms

SCS Summer School 2015 Past Exam Question Russell Cox.

Crude oil S2 Chemistry Materials from the Earth. Learning outcomesSuccess criteria Know how crude oil is extracted.Describe how crude oil is extracted.

M. Ansari Pharm D, PhD Associate Professor of Pharmaceutics.

Food Chemistry Chapter 17 in Green / Damjii Chapter X in Nuess Chapter X in Oxford Study (no resource in Chang)

Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.

Desiccation ,sublimation & tirturation

1. To learn about the composition of matter 2. To learn the difference between elements and compounds 3. To define the three states of matter.

INTRODUCTION TO ANALYTICAL CHEMISTRY ERT 207 ANALYTICAL CHEMISTRY SEMESTER 1, ACADEMIC SESSION 2015/16.

Kh. Sadique Faisal Asst. Lecturer Northern University Bangladesh

PROPERTIES OF MATTER PHYSICAL AND CHEMICAL. PHYSICAL PROPERTIES: can be used: -to identify a material, -to choose a material for a specific purpose, -to.

Process Skill demonstrate safe practices during laboratory and field investigations, including chemical, electrical, and fire safety, and safe handling.

1 Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July , 2008 Classification of Orally Disintegrating Tablets Frank O. Holcombe,

NDAC December 14, Nonprescription Drugs Advisory Committee Meeting Silver Spring, Maryland December 14, 2007 Mary S. Robinson, MS Division of Nonprescription.

Topical Preparation Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.

CHEMISTRY Matter and Change

1 Suspension 1. 2  Suspension:  Suspension: A suspension is a two-phase system consisting of a finely divided solid particles dispersed in liquid, or.

Post Graduate Job Oriented Add-on Course in Applied Chemistry.

AWAST Kick-off meeting - Orléans, February 12-13, 2001 Workpackage WP7 Model integration Simulator development and Validation u Integration of the models.

Predicting Physical Stability in Q1A(R) Chi-wan Chen, Ph.D. Office of New Drug Chemistry Center for Drug Evaluation and Research Food and Drug Administration.

Stability Trials ASEAN Guidelines. The Objective of a stability study To determine the shelf life, namely the time period of storage at a specified condition.

CHARACTERISATION OF COLLOIDS

Rapid Response Team Nakissa Sadrieh, Ph.D. Associate Director for Research Policy and Implementation, OPS.

Semisolid Dosage Forms

Progress presentation

Ch. 2.2 Mixtures.

Pharmaceutics I صيدلانيات 1 Unit 1 Introduction

Lawrence X. Yu, Ph.D. Director for Science Office of Generic Drugs, OPS, CDER, FDA ACPS Meeting, ACPS Meeting, Oct. 22, 2003 Office of Generic Drugs Research.

Most everyday matter occurs as mixtures—combinations of two or more substances. Section 3: Mixtures of Matter K What I Know W What I Want to Find Out L.

THERMAL ANALYSIS FOR PREFORMULATION TRIALS

Ointments, Creams, Pastes, and Gels

Solutions, Suspensions, and Emulsions

Gel Filtration Chromatography.

Part One Physical Properties Properties of Matter.

Classification of Matter

List the 5 phases of matter

SCIENCE GRADE THREE – STATES OF MATTER

Classifying Matter Physical Science.

Mixing and Homogenization Lab (1) Shahen S. Mohammed MSc pharmaceutics

Cosmetic Dosage Forms.

Basics of Chemistry Module 12 – 16’.

Thinking about water’s properties

List the 5 phases of matter

Capsule Dosage Form Lab (5)

Hemin J Majeed MSc. Pharmaceutical sciences

0:56 0:55 0:54 0:53 0:57 0:58 1:02 1:01 1:00 0:59 0:52 0:51 0:44 0:43 0:42 0:41 0:45 0:46 0:50 0:49 0:48 0:47 1:03 1:04 1:19 1:18 1:17 1:16 1:20 1:21 1:25.

The science of chemistry

Hemin J Majeed MSc. Pharmaceutical sciences

Presentation transcript:

Topical Dosage Form Classification/Nomenclature Questions Advisory Committee of Pharmaceutical Science Meeting March 12, 2003 Yuan-yuan Chiu, Ph.D. Director, ONDC/OPS/CDER/FDA

Question #1 The appearance and feel of a topical dosage form is part of the proposed definitions. In conversation with practitioners and evaluation of the literature, words such as greasy, non-greasy and cooling are often used when describing these dosage forms. Is there any value in including these attributes in the definitions?

Question #2 Laboratory work found viscosity to be the most discriminating property that separated lotions from creams. In addition, most literature sources describe lotions as liquids and creams as semisolids. In the proposed definitions, lotion is distinguished from cream based on “pourablility” which we found in the lab to be a viscosity less than 30,000 cp using the Brookfield viscometer at 25 o C and 5rpm. Is this reasonable?

Question #3 Laboratory work found LOD (Loss on Drying) to be a discriminating property that separated ointments from creams. In addition, a review of the current submissions to ONDC and OGD found that ointments had large percentages of hydrocarbons or PEGs in their bases. In the proposed definitions, ointment is distinguished from cream based on the proportions of volatiles ( 50%). Is this reasonable?

Question #4 The distinction between hydrophilic and lipophilic creams is made based on the composition of the continuous phase. Is there any value in including these two types of creams in the definitions?

Question #5a Gel is distinguished from cream based on the presence of sufficient quantities of a gelling agent to form three-dimensional, cross-linked matrix. Is this reasonable? Should “sufficient quantities” be defined? Which literature sources should be used as references?

Question #5b Some currently marketed “gels” contain an emulsifier that gives the dosage form an opaque appearance. Should the presence of an emulsifier in a formulation preclude a dosage form from being classified as a gel? Should it then be considered a cream instead of gel?

Question #5c What is the most appropriate analytical technique that can be used to identify the three dimensional structure of a gel?

Question #6 Is the overall approach taken in the proposed definitions appropriate?